Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/10501
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurthy, T E G K-
dc.contributor.authorPriya, M Bala Vishnu-
dc.contributor.authorSatyanarayana, V-
dc.date.accessioned2010-10-28T10:46:27Z-
dc.date.available2010-10-28T10:46:27Z-
dc.date.issued2010-11-
dc.identifier.issn0975-1084 (Online); 0022-4456 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/10501-
dc.description866-871en_US
dc.description.abstractMetered dose inhalers (MDIs) of fluticasone propionate were developed for treatment of asthma and chronic ob­structive pulmonary disease. MDIs with hydrofluoroalkanes based propellants were formulated with various doses, overages and various concentrations of alcohol. Optimum requirements were found as follows: effective valve delivery, overdoses (15%); 100% drug delivery, overages (20%); and emitted dose and fine particle fraction, alcohol content (5-10%).en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceJSIR Vol.69(11) [November 2010]en_US
dc.subjectEmitted doseen_US
dc.subjectFluticasone propionateen_US
dc.subjectMetered dose inhalersen_US
dc.subjectOveragesen_US
dc.subjectSpray patternen_US
dc.subjectValve deliveryen_US
dc.titlePerformance of CFC free propellant- driven MDI of fluticasone propionateen_US
dc.typeArticleen_US
Appears in Collections:JSIR Vol.69(11) [November 2010]

Files in This Item:
File Description SizeFormat 
JSIR 69(11) 866-871.pdf275.28 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.